These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25492482)

  • 1. p53 suppresses CCL2-induced subcutaneous tumor xenograft.
    Tang X; Amar S
    Tumour Biol; 2015 Apr; 36(4):2801-8. PubMed ID: 25492482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 is an important regulator of CCL2 gene expression.
    Tang X; Asano M; O'Reilly A; Farquhar A; Yang Y; Amar S
    Curr Mol Med; 2012 Sep; 12(8):929-43. PubMed ID: 22804246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
    Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.
    Li S; Li X; Zhao H; Gao M; Wang F; Li W
    Mol Med Rep; 2015 Oct; 12(4):5482-6. PubMed ID: 26151241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
    Qin Y; Cui H; Zhang H
    Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression.
    Chen LM; Liu PY; Chen YA; Tseng HY; Shen PC; Hwang PA; Hsu HL
    Sci Rep; 2017 Sep; 7(1):11864. PubMed ID: 28928376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
    Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
    Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2.
    Liu T; Miao Z; Jiang J; Yuan S; Fang W; Li B; Chen Y
    Int J Mol Sci; 2015 May; 16(5):11439-51. PubMed ID: 25993304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
    Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-box transcription factor Brachyury in lung cancer cells inhibits macrophage infiltration by suppressing CCL2 and CCL4 chemokines.
    Chen S; Jiao J; Jiang D; Wan Z; Li L; Li K; Xu L; Zhou Z; Xu W; Xiao J
    Tumour Biol; 2015 Aug; 36(8):5881-90. PubMed ID: 25744730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol.
    Mukhopadhyay T; Roth JA
    Oncogene; 1997 Jan; 14(3):379-84. PubMed ID: 9018125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
    Lu WJ; Chua MS; So SK
    Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.